Latest Articles

Publication Date
The Reproductive Tract Microbiome and Female Fertility: Dysbiosis, Disease Links, and Emerging Therapeutic Strategies.

The reproductive tract microbiome plays a pivotal role in female fertility, with Lactobacillus-dominated communities maintaining a protective, low-pH environment. Dysbiosis-characterized by a reduction in Lactobacillus species and overgrowth of anaerobes-is …

Published: Jan. 21, 2026, midnight
Significance of Follicle-Stimulating Hormone Receptor Gene Single-Nucleotide Polymorphism rs6165/rs6166 Analysis for Infertility-Associated Ovarian Disease Susceptibility Prediction and Optimized Individualized Ovulation Induction/Ovarian Stimulation.

Follicle-stimulating hormone receptor (FSHR) is expressed on the plasma membrane of granulosa cells in the ovarian follicles. FSHR is involved in the development and maturation of Graafian follicles, along with …

Published: Jan. 10, 2026, midnight
Addressing Meta-Inflammation in the Comprehensive Management of Chronic Pain.

Chronic pain is a widespread condition affecting millions globally, placing significant strain on healthcare systems, as evidenced by the current opioid crisis. Despite advances in pain management, conventional treatments often …

Published: Oct. 18, 2025, midnight
Metformin Plus Letrozole and Abemaciclib Induces CRs in ER+ Recurrent Endometrial Cancer - OncLive

Metformin Plus Letrozole and Abemaciclib Induces CRs in ER+ Recurrent Endometrial Cancer OncLive

Published: Sept. 16, 2025, 2:01 p.m.
Dr Konstantinopoulos on Responses With Metformin Plus Letrozole/Abemaciclib in ER+ Endometriod Endometrial Cancer - OncLive

Dr Konstantinopoulos on Responses With Metformin Plus Letrozole/Abemaciclib in ER+ Endometriod Endometrial Cancer OncLive

Published: April 9, 2025, 2 p.m.
Metformin Plus Letrozole & Abemaciclib Appears Safe, Effective in Endometrial Cancer - Oncology Nurse Advisor

Metformin Plus Letrozole & Abemaciclib Appears Safe, Effective in Endometrial Cancer Oncology Nurse Advisor

Published: April 3, 2025, 4 a.m.
Metformin in gynecological disorders: pathogenic insights and therapeutic implications - Frontiers

Metformin in gynecological disorders: pathogenic insights and therapeutic implications Frontiers

Published: March 31, 2025, 10:26 a.m.
University of Cincinnati Cancer Center Reports Metformin Enhances Treatment in ER-Positive Endometrial Cancer - Hoodline

University of Cincinnati Cancer Center Reports Metformin Enhances Treatment in ER-Positive Endometrial Cancer Hoodline

Published: March 24, 2025, 7:46 p.m.
Add-on metformin promising in ER-positive endometrial cancer - University of Cincinnati

Add-on metformin promising in ER-positive endometrial cancer University of Cincinnati

Published: March 24, 2025, 5:05 p.m.
Metformin Restores Endometrial Health in PCOS - Technology Networks

Metformin Restores Endometrial Health in PCOS Technology Networks

Published: March 21, 2025, 9:03 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!